News

Sanofi-Aventis: Dengue fever vaccine in clinical development

BY Alaric DeArment

LYON, France A vaccine for the mosquito-borne illness dengue fever is in the final stages of development, Sanofi-Aventis said Thursday.

 

Sanofi said the first phase-3 trial of the vaccine was under way in Australia.

 

 

The study is part of a worldwide phase-3 trial program to develop the vaccine for children and adults. Currently, there is no specific treatment available for the disease, which threatens nearly 3 billion people worldwide, particularly in Latin America and Asia. Dengue fever is a virus that infects around 220 million people every year, 2 million of whom — most of them children — develop dengue hemorrhagic fever.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
News

CNE announces partnership with Hallmark Cards

BY Allison Cerra

NEW YORK Cartoon Network’s global licensing and merchandising arm has inked a deal with a greeting card manufacturer.

Cartoon Network Enterprises said its long-term partnership with Hallmark Cards will include greeting cards and party supply items based on Cartoon Network’s portfolio of brands, including Ben 10 Ultimate Alien, Generator Rex and Adventure Time, CNE said.

Hallmark’s product offerings will be available throughout North America.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Net sales jump in Q3 for Drugstore.com

BY Michael Johnsen

BELLEVUE, Wash. Drugstore.com on Tuesday reported a 23% increase in net sales to $108.8 million for the third quarter ended Oct. 3.

 

“Including a strong performance from SkinStore.com, over-the-counter sales increased 26% year-over-year,” stated Dawn Lepore, CEO and chairman at Drugstore.com. “During the quarter, we did experience supply constraints from a few of our major vendors and some softness in discretionary spending, which impacted growth and resulted in increased promotions,” she said. “[But] with continued growth in our [over-the-counter] and vision segments, we remain on track to hit our 2010 goals of OTC revenue growth of 24% to 28%, doubling our prestige beauty business and delivering $16 to $20 million in revenues from our partnerships.”

 

 

For fourth quarter 2010, Drugstore.com is targeting net sales in the range of $118 million to $122 million. As a reminder, fourth quarter 2010 is a 13-week period and compares with a 14-week period in fourth quarter 2009, the online retailer stated.

 

 

Drugstore.com served approximately 447,000 new customers, excluding strategic partnerships, during the quarter, up 21% over the same period in the prior year. Marketing and sales expense per new customer, excluding partnership orders, increased to $25.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?